Provided by Tiger Trade Technology Pte. Ltd.

PHARMARON

15.220
+0.1701.13%
Volume:3.41M
Turnover:51.55M
Market Cap:27.85B
PE:14.03
High:15.380
Open:14.810
Low:14.770
Close:15.050
52wk High:30.120
52wk Low:14.450
Shares:1.83B
HK Float Shares:353.00M
Volume Ratio:0.82
T/O Rate:0.97%
Dividend:0.23
Dividend Rate:1.52%
EPS(LYR):1.085
ROE:9.99%
ROA:4.90%
PB:1.47
PE(LYR):14.03
PS:1.65

Loading ...

Pharmaron Records Stable Share Capital and Confirms Public Float Compliance in April 2026

Bulletin Express
·
May 06

Stock Track | Pharmaron Plummets 5.10% Intraday Amid Shareholder Reduction Plans and Sector Weakness

Stock Track
·
May 05

Pharmaron Beijing Shareholders Plan to Reduce Holdings by Up to 1.5%

Stock News
·
Apr 30

PHARMARON Announces Share Pledge and Release of 11 Million Shares by Controlling Shareholder

Stock News
·
Apr 29

Pharmaron Nominates New Board Director Candidates

Stock News
·
Apr 28

PHARMARON Reports First-Quarter Net Profit of 335 Million Yuan, Up 9.75%

Stock News
·
Apr 28

Pharmaron releases 2025 Annual Report and ESG Report; online access now open, printed copies available on request

Bulletin Express
·
Apr 28

PHARMARON posts 2025 Annual and ESG reports online; shareholders may request free printed copies

Bulletin Express
·
Apr 28

Pharmaron 2025年报:营收达140.951亿元,IFRS净利同比下滑7.2%,多元化研发格局稳步拓展

Bulletin Express
·
Apr 28

Stock Track | Pharmaron Soars 6.60% Intraday as Biotech Sector Rallies on Wuxi Apptec's Strong Earnings

Stock Track
·
Apr 28

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress
·
Apr 23

JPMorgan Reduces Stake in Pharmaron by Approximately 605,000 Shares at HK$21.39 Per Share

Stock News
·
Apr 22

CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase

Stock News
·
Apr 17

Pharmaron Beijing Sets 28 April 2026 Board Meeting to Approve Q1 2026 Results

Bulletin Express
·
Apr 14

Morgan Stanley Raises Pharmaron Target Price to HK$31.5, Keeps Overweight Rating

Stock News
·
Apr 14

HK Movers | Pharmaceutical Stocks Rally With Joinn up 7%

Tiger Newspress
·
Apr 09

IEA Warns of Doubling Oil Supply Gap in April; US Launches Manned Moon Mission Rocket

Stock News
·
Apr 02

Stock Track | PHARMARON Soars 11.69% Intraday on Strong Q4 Earnings and Robust New Order Growth

Stock Track
·
Apr 01

PHARMARON Shares Surge Over 7% on Strong Performance Acceleration and Double-Digit New Order Growth

Stock News
·
Apr 01